文献速递医学教育与科研方法流行病学与生物统计

学术界提升价值与减少浪费的回应:面向患者导向学术临床研究的INQUIRE综合质量框架

Academic response to improving value and reducing waste: A comprehensive framework for INcreasing QUality In patient-oriented academic clinical REsearch (INQUIRE).
PubMed 文献 · PLoS Med · 2018-06-07

研究通过系统综述质量定义与标准,结合13国利益相关方网站信息,并经4轮改良在线德尔菲流程在16国7类利益相关方中达成共识,构建了覆盖研究5个阶段和6个质量维度的INQUIRE框架。该框架为学术机构评估和改进患者导向临床研究质量、减少可避免浪费提供了共同结构。

要点

  • INQUIRE框架覆盖从概念到知识转化的5个研究阶段,每个阶段均设质量评估问题。
  • 框架包含患者安全与权益保护、相关性/患者中心性、偏倚最小化、精确性、透明度、外推性6个质量维度。
  • 该框架已在瑞士临床试验组织网络中转化为路线图,指导质量提升举措。

核心结论

  • INQUIRE框架为学术机构在患者导向临床研究全阶段评估质量、减少可避免浪费提供了利益相关方共识基础。

研究设计与样本

  • 基于截至2015年2月15日的MEDLINE系统检索及13国利益相关方网站信息,系统开发质量框架。
  • 在16国7类利益相关方中开展4轮改良在线德尔菲流程,最终就框架结构与内容达成共识。

主要发现

  • 框架覆盖概念、规划与可行性、实施、分析与解释、报告与知识转化5个研究阶段。
  • 框架包含患者安全与权益保护、相关性/患者中心性与参与、偏倚最小化(内部真实性)、精确性、透明度/数据可及性、外推性(外部真实性)6个质量维度。
  • 基础设施与通过教育实现的可持续性作为2个促进因素,可能增强所有质量维度。
  • 最终一轮调查中,来自9个国家的德尔菲参与者就研究阶段、质量维度、具体问题及描述性示例的结构、内容和措辞达成一致。
  • 在瑞士,INQUIRE已形成路线图,指导瑞士临床试验组织网络及附属研究人员提升价值的举措。

关键数值与推荐

  • 每个质量维度包含具体问题和解释性条目,指导从研究问题概念化到报告与知识转化的各阶段质量评估。
  • 德尔菲流程最终就框架的结构与内容达成共识,最后一轮由9国参与者确认研究阶段、质量维度、具体问题及描述性示例的措辞。

临床怎么用

  • 学术机构和研究人员可运用INQUIRE框架在研究各阶段开展质量评估,指导质量提升举措的制定。
  • 框架可从提出正确研究问题到透明发表结果,全程支持减少研究浪费、提升研究价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Compelling evidence has demonstrated that a large proportion of investment in biomedical research is wasted; this waste is avoidable. Academic institutions have, thus far, shown limited response to recommendations for increasing value and reducing waste. We formulated an academic response by (i) achieving consensus across a wide range of stakeholder groups on a comprehensive framework for quality of patient-oriented clinical research and (ii) highlighting first successful examples of its operationalization to facilitate waste-reducing strategies at academic institutions. METHODS AND FINDINGS: Based on a systematic review of quality definitions, concepts, and criteria in the medical literature (systematic MEDLINE search up to February 15, 2015, with independent and in duplicate article selection) and on stakeholder websites from 13 countries (Australia, Austria, Canada, France, Germany, Italy, Japan, Norway, Spain, Sweden, Switzerland, United Kingdom, and United States), we systematically developed a comprehensive framework for the quality of clinical research. We identified websites through personal contacts with experts in clinical research or public health who also suggested, for each country, websites of the following 7 stakeholder groups: patient organizations; academic research infrastructures; governmental bodies; regulatory agencies; ethics committees; the pharmaceutical industry; and funding agencies. In addition, we searched websites of inter- or supranational bodies involved in clinical research until no further insights emerged. After consolidation of the identified definitions, concepts, and criteria of quality in a basic framework structure, we conducted 4 rounds of an adapted online Delphi process among the same 7 stakeholder groups from 16 countries. The Delphi process ultimately achieved consensus on structure and content. The framework addresses 5 study stages (concept, planning and feasibility, conduct, analysis and interpretation, and reporting and knowledge translation) and includes the following dimensions: (i) protection of patient safety and rights, (ii) relevance/patient centeredness and involvement, (iii) minimization of bias (internal validity), (iv) precision, (v) transparency/access to data, and (vi) generalizability (external validity) of study results. These dimensions interact with 2 promoters-infrastructure and sustainability through education-that include a set of factors that may enhance all listed quality dimensions. Each quality dimension contains specific questions and explanatory items that guide quality assessment at each research stage from conceptualization of the research question through reporting and knowledge translation of study results. In the last survey round, Delphi participants from 9 countries (Austria, Australia, Canada, Germany, Italy, the Netherlands, Switzerland, UK, and US) agreed on the structure, content, and wording of the research stages, quality dimensions, specific questions, and descriptive examples of the final framework. In Switzerland, INQUIRE has resulted in a roadmap that guides initiatives to increase value within the Swiss Clinical Trial Organization network and through affiliated researchers. CONCLUSIONS: We present a framework based on a consensus of different stakeholder groups guiding the practical assessment of clinical research quality at all stages of a research project. Operationalization of this common structure will support the increase of value by guiding academic institutions and researchers in developing quality enhancement initiatives, from posing the right research question to the transparent publication of results.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. von Niederhäusern B, Guyatt GH, Briel M, et al. Academic response to improving value and reducing waste: A comprehensive framework for INcreasing QUality In patient-oriented academic clinical REsearch (INQUIRE). PLoS Med. 2018. PMID: 29879117. doi:10.1371/journal.pmed.1002580

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。